Biophysical and ultrastructural characterization of adeno-associated virus capsid uncoating and genome release

Journal of Virology

Volumn 87, Issue 6, 2013, Pages 2994-3002

  Horowitz, Eric D ^a   Rahman, K Shefaet ^b   Bower, Brian D ^a   Dismuke, David J ^a   Falvo, Michael R ^a   Griffith, Jack D ^c   Harvey, Stephen C ^b   Asokan, Aravind ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; PARVOVIRUS VECTOR; PROTEIN VP1; SELF COMPLEMENTARY DNA; SINGLE STRANDED DNA; TUNGSTEN; UNCLASSIFIED DRUG; VIRUS DNA;

ACIDITY; ADENO ASSOCIATED VIRUS; AMINO TERMINAL SEQUENCE; ARTICLE; ATOMIC FORCE MICROSCOPY; BASE PAIRING; BIOPHYSICS; CELL PH; CONTROLLED STUDY; DNA PACKAGING; DNA STRUCTURE; FLUOROMETRY; GENETIC COMPLEMENTATION; GENOME SIZE; HEATING; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; NONHUMAN; OSMOTIC PRESSURE; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; THERMOSTABILITY; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CAPSID; VIRUS GENOME; VIRUS GENOME RELEASE; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS UNCOATING; WILD TYPE;

CAPSID; DEPENDOVIRUS; DNA, VIRAL; FLUOROMETRY; HOT TEMPERATURE; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON; OSMOTIC PRESSURE; VIRUS UNCOATING;

EID: 84874744189     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03017-12     Document Type: Article

References (46)

1. Bowles DE, Rabinowitz JE, Samulski RJ. 2006. The genus Dependovirus, p 15-24. In Kerr JR, Cotmore SF, Bloom ME, Linden RM, ParrishCR(ed), Parvoviruses. Hodder Arnold Publishers, London, United Kingdom.
2. Samulski RJ, Srivastava A, Berns KI, Muzyczka N. 1983. Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell 33:135-143.
3. Xiao X, Xiao W, Li J, Samulski RJ. 1997. A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J. Virol. 71:941-948.
4. Agbandje-McKenna M, Kleinschmidt J. 2011. AAV capsid structure and cell interactions. Methods Mol. Biol. 807:47-92.
5. Mingozzi F, High KA. 2011. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 12:341-355.
6. Ding W, Zhang L, Yan Z, Engelhardt JF. 2005. Intracellular trafficking of adeno-associated viral vectors. Gene Ther. 12:873-880.
7. Nonnenmacher M, Weber T. 2012. Intracellular transport of recombinant adeno-associated virus vectors. Gene Ther. 19:649-658.
8. McCarty DM. 2008. Self-complementary AAV vectors; advances and applications. Mol. Ther. 16:1648-1656.
9. Hauck B, Zhao W, High K, Xiao W. 2004. Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno- associated virus transduction. J. Virol. 78:13678-13686.
10. Ferrari FK, Samulski T, Shenk T, Samulski RJ. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
11. Fisher KJ, Gao GP, Weitzman MD, DeMatteo R, Burda JF, Wilson JM. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:520-532.
12. Dong B, Nakai H, Xiao W. 2010. Characterization of genome integrity for oversized recombinant AAV vector. Mol. Ther. 18:87-92.
13. Grieger JC, Samulski RJ. 2005. Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. J. Virol. 79:9933-9944.
14. Hirsch ML, Agbandje-McKenna M, Samulski RJ. 2010. Little vector, big gene transduction: fragmented genome reassembly of adeno-associated virus. Mol. Ther. 18:6-8.
15. Lai Y, Yue Y, Duan D. 2010. Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome or 8.2 kb. Mol. Ther. 18:75-79.
16. Wu J, Zhao W, Zhong L, Han Z, Li B, Ma W, Weigel-Kelley KA, Warrington KH, Srivastava A. 2007. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Hum. Gene Ther. 18:171-182.
17. Wu Z, Yang H, Colosi P. 2010. Effect of genome size on AAV vector packaging. Mol. Ther. 18:80-86.
18. Cotmore SF, Hafenstein S, Tattersall P. 2010. Depletion of virionassociated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3=-to-5= direction from an otherwise intact viral particle. J. Virol. 84:1945-1956.
19. Carrasco C, Carreira A, Schaap IA, Serena PA, Gomez-Herrero J, Mateu MG, de Pablo PJ. 2006. DNA-mediated anisotropic mechanical reinforcement of a virus. Proc. Natl. Acad. Sci. U. S. A. 103:13706-13711.
20. Horowitz ED, Finn MG, Asokan A. 2012. Tyrosine cross-linking reveals interfacial dynamics in adeno-associated viral capsids during infection. ACS Chem. Biol. 7:1059-1066.
21. Johnson JS, Li C, DiPrimio N, Weinberg MS, McCown TJ, Samulski RJ. 2010. Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction. J. Virol. 84:8888-8902.
22. Kronenberg S, Bottcher B, von der Lieth CW, Bleker S, Kleinschmidt JA. 2005. A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini. J. Virol. 79:5296-5303.
23. Grieger JC, Choi VW, Samulski RJ. 2006. Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1:1412-1428.
24. Samulski RJ, Chang LS, Shenk T. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
25. Pulicherla N, Shen S, Yadav S, Debbink K, Govindasamy L, Agbandje- McKenna M, Asokan A. 2011. Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer. Mol. Ther. 19:1070-1078.
26. DiPrimio N, Asokan A, Govindasamy L, Agbandje-McKenna M, Samulski RJ. 2008. Surface loop dynamics in adeno-associated virus capsid assembly. J. Virol. 82:5178-5189.
27. Gradinaru V, Zhang F, Ramakrishnan C, Mattis J, Prakash R, Diester I, Goshen I, Thompson KR, Deisseroth K. 2010. Molecular and cellular approaches for diversifying and extending optogenetics. Cell 141:154-165.
28. Gray SJ, Foti SB, Schwartz JW, Bachaboina L, Taylor-Blake B, Coleman J, Ehlers MD, Zylka MJ, McCown TJ, Samulski RJ. 2011. Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using selfcomplementary vectors. Hum. Gene Ther. 22:1143-1153.
29. Torikai K, Ito M, Jordan LE, Mayor HD. 1970. Properties of light particles produced during growth of type 4 adeno-associated satellite virus. J. Virol. 6:363-369.
30. Wobus CE, Hugle-Dorr B, Girod A, Petersen G, Hallek M, Kleinschmidt JA. 2000. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J. Virol. 74:9281-9293.
31. Compton SA, Ozgur S, Griffith JD. 2010. Ring-shaped Rad51 paralog protein complexes bind Holliday junctions and replication forks as visualized by electron microscopy. J. Biol. Chem. 285:13349-13356.
32. Griffith JD, Lee S, Wang YH. 1997. Visualizing nucleic acids and their complexes using electron microscopy. Curr. Opin. Struct. Biol. 7:362-366.
33. Locker CR, Harvey SC. 2006. A model for viral genome packing. Multiscale Modeling Simulation 5:1264-1279.
34. Cerritelli ME, Cheng N, Rosenberg AH, McPherson CE, Booy FP, Steven AC. 1997. Encapsidated conformation of bacteriophage T7 DNA. Cell 91:271-280.
35. Xie Q, Bu W, Bhatia S, Hare J, Somasundaram T, Azzi A, Chapman MS. 2002. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. U. S. A. 99:10405-10410.
36. Plimpton S. 1995. Fast parallel algorithms for short-range molecular dynamics. J. Comput. Phys. 117:1-19.
37. Nosé S. 1984. A molecular dynamics method for simulations in the canonical ensemble. Mol. Phys. 52:255-268.
38. Tuma RS, Beaudet MP, Jin X, Jones LJ, Cheung CY, Yue S, Singer VL. 1999. Characterization of SYBR gold nucleic acid gel stain: a dye optimized for use with 300-nm ultraviolet transilluminators. Anal. Biochem. 268: 278-288.
39. Gerlach B, Kleinschmidt JA, Bottcher B. 2011. Conformational changes in adeno-associated virus type 1 induced by genome packaging. J. Mol. Biol. 409:427-438.
40. Theodorakopoulos N, Peyrard M. 2012. Base pair openings and temperature dependence of DNA flexibility. Phys. Rev. Lett. 108:078104. doi:10 .1103/PhysRevLett.108.078104.
41. Ivanovska I, Wuite G, Jonsson B, Evilevitch A. 2007. Internal DNA pressure modifies stability of WT phage. Proc. Natl. Acad. Sci. U. S. A. 104:9603-9608.
42. Petrov AS, Harvey SC. 2008. Packaging double-helical DNA into viral capsids: structures, forces, and energetics. Biophys. J. 95:497-502.
43. Locker CR, Fuller SD, Harvey SC. 2007. DNA organization and thermodynamics during viral packing. Biophys. J. 93:2861-2869.
44. Purohit PK, Inamdar MM, Grayson PD, Squires TM, Kondev J, Phillips R. 2005. Forces during bacteriophage DNA packaging and ejection. Biophys. J. 88:851-866.
45. Smith DE, Tans SJ, Smith SB, Grimes S, Anderson DL, Bustamante C. 2001. The bacteriophage straight phi29 portal motor can package DNA against a large internal force. Nature 413:748-752.
46. Evilevitch A, Lavelle L, Knobler CM, Raspaud E, Gelbart WM. 2003. Osmotic pressure inhibition of DNA ejection from phage. Proc. Natl. Acad. Sci. U. S. A. 100:9292-9295.